Towards efficient immunotherapy for bacterial infection

生物 抗生素耐药性 重症监护医学 抗生素 疾病 抗生素治疗 传染病(医学专业) 抗菌剂 免疫疗法 免疫系统 微生物学 免疫学 医学 内科学
作者
Timothy R. McCulloch,Timothy J. Wells,Fernando Souza‐Fonseca‐Guimaraes
出处
期刊:Trends in Microbiology [Elsevier BV]
卷期号:30 (2): 158-169 被引量:80
标识
DOI:10.1016/j.tim.2021.05.005
摘要

Immunotherapy has revolutionized the treatment of cancer through the reversal of immunosuppression. Development of antibiotic resistance is a concerning trend that is reducing treatment options for bacterial infection. Cancer and bacterial infections share many hallmarks of suppression, suggesting that immunotherapy could also be a revolutionary tool for clinics to treat bacterial infections, including troublesome persistent and antibiotic-resistant infections such as tuberculosis. Preclinical data are rapidly emerging, showing that immune checkpoint inhibition, modulation of cytokines, and cellular therapies hold great promise for treating various bacterial infections. Clinical trials are urgently needed to determine the effectiveness and safety of utilizing immunotherapy in the face of the looming antibiotic-resistance crisis. The emergence of multiantibiotic-resistant bacteria, often referred to as superbugs, is leading to infections that are increasingly difficult to treat. Further, bacteria have evolved mechanisms by which they subvert the immune response, meaning that even antibiotic-sensitive bacteria can persist through antibiotic therapy. For these reasons, a broad range of viable therapeutic alternatives or conjunctions to traditional antimicrobial therapy are urgently required to reduce the burden of disease threatened by antibiotic resistance. Immunotherapy has emerged as a leading treatment option in cancer, and researchers are now attempting to apply this to infectious disease. This review summarizes and discusses the recent advances in the field and highlights current and future perspectives of using immunotherapies to treat bacterial infections. The emergence of multiantibiotic-resistant bacteria, often referred to as superbugs, is leading to infections that are increasingly difficult to treat. Further, bacteria have evolved mechanisms by which they subvert the immune response, meaning that even antibiotic-sensitive bacteria can persist through antibiotic therapy. For these reasons, a broad range of viable therapeutic alternatives or conjunctions to traditional antimicrobial therapy are urgently required to reduce the burden of disease threatened by antibiotic resistance. Immunotherapy has emerged as a leading treatment option in cancer, and researchers are now attempting to apply this to infectious disease. This review summarizes and discusses the recent advances in the field and highlights current and future perspectives of using immunotherapies to treat bacterial infections. an aggregate of immune cells, predominantly macrophages, which act to constrain infectious organisms in order to prevent dissemination. A granuloma can also contribute to the persistence of infection by hiding infectious organisms from the immune response or from antimicrobial drugs. liver-resident macrophages. macrophages have been historically classified into two polarization states, with proinflammatory macrophages designated 'M1' or 'classically activated', and anti-inflammatory macrophages designated 'M2' or 'alternatively activated'. While it is now clear that this paradigm is outdated and does not reflect the true spectrum of macrophage classifications, we have used 'M1-like' and 'M2-like' here for simplicity in describing macrophages with bactericidal or regulatory phenotypes, respectively. subpopulations of bacteria which have transient tolerance to antibiotic therapy due to dormancy induced in response to environmental stress. This tolerant state differs from that of antibiotic-resistant bacteria, which arises from heritable mutations, as the progeny of persister cells revert to antibiotic sensitivity when replicating. Persister cells are thought to be a major contributor to recalcitrance and relapse of certain persistent bacterial infections. a subpopulation of bacteria with attenuated growth as a result of mutations, usually in genes encoding the electron transport chain or thymidine biosynthesis, allowing them to tolerate antibiotic therapy while also surviving within host cells. Similar to persister cells, this contributes to persistence of infection; however, in the case of small-colony variants persistence is due to heritable and permanent changes in bacterial growth as opposed to transient adaptations to environmental stress.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
liu完成签到,获得积分20
1秒前
2秒前
3秒前
侃侃完成签到,获得积分10
5秒前
5秒前
6秒前
万能图书馆应助安徒采纳,获得10
6秒前
7秒前
Dyson发布了新的文献求助30
7秒前
8秒前
祝您发财关注了科研通微信公众号
8秒前
陈诺发布了新的文献求助10
9秒前
徐徐诱之完成签到,获得积分10
10秒前
犹豫的蜜蜂完成签到,获得积分10
11秒前
cruise发布了新的文献求助10
11秒前
凡迪亚比应助科研通管家采纳,获得10
12秒前
yx_cheng应助科研通管家采纳,获得20
12秒前
香蕉觅云应助科研通管家采纳,获得10
12秒前
年轻馒头应助科研通管家采纳,获得20
12秒前
12秒前
Akim应助科研通管家采纳,获得10
12秒前
12秒前
彭于晏应助科研通管家采纳,获得10
12秒前
12秒前
12秒前
12秒前
威武的翠安完成签到 ,获得积分10
13秒前
科研通AI5应助如意的听云采纳,获得10
13秒前
陈诺完成签到,获得积分10
14秒前
14秒前
sunguoyi完成签到,获得积分10
14秒前
苏先生完成签到,获得积分10
14秒前
DduYy完成签到,获得积分10
14秒前
澡雪发布了新的文献求助10
15秒前
自由寻冬完成签到 ,获得积分10
15秒前
CR7应助mm采纳,获得20
15秒前
16秒前
liuxian完成签到 ,获得积分10
17秒前
桐桐应助cruise采纳,获得10
17秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3975693
求助须知:如何正确求助?哪些是违规求助? 3520019
关于积分的说明 11200635
捐赠科研通 3256410
什么是DOI,文献DOI怎么找? 1798255
邀请新用户注册赠送积分活动 877490
科研通“疑难数据库(出版商)”最低求助积分说明 806390